OC
Ocular Therapeutix, Inc.
OCUL · NASDAQ
$9.99 -1.58% (-$0.16)
1M -7.33%
Market Cap $2.22B
P/E Ratio -
Div. Yield -
ROE 59.87%
Bulios Fair Price
$13.03
30.4% upside
Trenutna cena
$9.99
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica OCUL trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
24 /100
Expensive P/B 4.27x
P/S 42.65x
PEG N/A
Growth
39 /100
Stable Book val. growth 164.45%
Rev. growth 0.21%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 490.07%
Op. margin 603.04%
Gross margin 87.11%
Quality
1 /100
Poor Asset turnover 0.08x
ROA 44.90%
ROIC 50.20%
Debt
69 /100
Low Current ratio 13.11x
Int. coverage -25.44x
Debt/Equity 0.15x
Stability
73 /100
Stable Profitable years 0
EPS volatility 7.59%
Beta 0.97x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OCUL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Pravin U. Dugel
Employees
325
Headquarters
Bedford
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report